Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tata Memorial Hospital
With
Indian Council of Medical Research
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with large operable lesions (pT/cT \> 5 cm) or locally advanced breast cancers undergoing modified radical mastectomy or breast conservative surgery-(BCS) who need adjuvant post operative radiotherapy
Patients post mastectomy requiring radiotherapy because of nodal positivity
Completed planned chemotherapy schedule
ER and/or PR positive patients
Patients decided to be put on tamoxifen
Patients reliable for follow up
You may not be if
Patients with BCT who have pT1 or pT2 breast lesions (N0,N1)
Patients for palliative radiotherapy to the chest wall/breast/supraclavicular fossa
Any patient requiring radiation to the axillary or internal mammary area
Recurrent disease or metastatic disease
Patients on concurrent chemotherapy and radiation
Clareo Health | Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients
